Steven Cohen’s Teva Pharmaceuticals TEVA Stock Holding History

Steven Cohen’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.56M	Buy	105,200 +27,000	+35%	+$899K	﹤0.01%	2004
2026 Q1	$2.36M	Buy	78,200 +71,400	+1,050%	+$2.3M	﹤0.01%	2199
2025 Q4	$212K	Sell	6,800 -260,500	-97%	-$6.42M	﹤0.01%	3621
2025 Q3	$5.4M	Buy	267,300 +42,400	+19%	+$745K	0.01%	1038
2025 Q2	$3.77M	Buy	224,900 +24,800	+12%	+$400K	0.01%	1060
2025 Q1	$3.08M	Buy	200,100 +151,500	+312%	+$2.71M	0.01%	1113
2024 Q4	$1.07M	Buy	+48,600	New	+$884K	﹤0.01%	1441
2024 Q1	–	Sell	-38,400	Closed	-$401K	–	2612
2023 Q4	$401K	Hold	38,400	–	–	﹤0.01%	1637
2023 Q3	$392K	Hold	38,400	–	–	﹤0.01%	1584
2023 Q2	$289K	Sell	38,400 -20,600	-35%	-$167K	﹤0.01%	1368
2023 Q1	$522K	Sell	59,000 -102,900	-64%	-$1.02M	﹤0.01%	1224
2022 Q4	$1.48M	Sell	161,900 -441,000	-73%	-$3.85M	0.01%	989
2022 Q3	$4.87M	Buy	602,900 +500,000	+486%	+$4.42M	0.02%	734
2022 Q2	$774K	Buy	+102,900	New	+$896K	﹤0.01%	1126
2020 Q3	–	Sell	-450,000	Closed	-$5.55M	–	1097
2020 Q2	$5.55M	Buy	+450,000	New	+$5.09M	0.04%	464
2017 Q2	–	Sell	-50,000	Closed	-$1.6M	–	1000
2017 Q1	$1.6M	Buy	+50,000	New	+$1.71M	0.01%	692
2016 Q1	–	Sell	-1,000,000	Closed	-$65.6M	–	843
2015 Q4	$65.6M	Hold	1,000,000	–	–	0.54%	41
2015 Q3	$56.5M	Buy	+1,000,000	New	+$64.8M	0.44%	51

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Steven Cohen's TEVA Position: Q2 2026 in Review

Steven Cohen reduced its Teva Pharmaceuticals (TEVA) stake by 6.3% in Q2 2026, selling an estimated $2.36M and leaving 1,059,778 shares worth $35.9M. The position accounts for 0.04% of the portfolio, ranked #580.

Steven Cohen first reported a position in TEVA in Q2 2014 and has held it in 27 quarters since. The position peaked at $90.7M in Q2 2018. 671 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Steven Cohen held 1,059,778 shares of Teva Pharmaceuticals worth $35.9M as of Q2 2026.
Steven Cohen sold 70,729 Teva Pharmaceuticals shares in Q2 2026, an estimated $2.36M.
Teva Pharmaceuticals made up 0.04% of Steven Cohen's portfolio in Q2 2026, its #580 holding.
Steven Cohen first reported a position in Teva Pharmaceuticals in Q2 2014 and has held it in 27 quarters since.
Steven Cohen's Teva Pharmaceuticals position peaked at $90.7M in Q2 2018.
671 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.